Literature DB >> 26741524

Investigating the Nature of Method Factors Through Multiple Informants: Evidence for a Specific Factor?

Guido Alessandri1, Michele Vecchione1, John Tisak2, Claudio Barbaranelli1.   

Abstract

When a self-report instrument includes a balanced number of positively and negatively worded items, factor analysts often use method factors to aid model fitting. The nature of these factors, often referred to as acquiescence, is still debated. Relying upon previous results ( Alessandri et al., 2010 ; DiStefano & Motl, 2006 , 2008 ; Rauch, Schweizer, & Moosbrugger, 2007 ), we submit that the so-called method factors, instead, represent substantive specific factors. This study investigates the convergence of method effects across different observers. The revised Life Orientation Test ( Scheier, Carver, & Bridges, 1994 ) was administered to a sample of 372 adults (57% females), with 372 acquaintances serving as informants. Results showed that a specific factor was detectable both with self- and other-ratings. A significant correlation across informants provided evidence for the convergence of this specific factor. Construct validity was examined by locating this specific factor within a nomological net of personality variables. Theoretical and practical implications of the findings are discussed.

Year:  2011        PMID: 26741524     DOI: 10.1080/00273171.2011.589272

Source DB:  PubMed          Journal:  Multivariate Behav Res        ISSN: 0027-3171            Impact factor:   5.923


  2 in total

1.  An application of the LC-LSTM framework to the self-esteem instability case.

Authors:  Guido Alessandri; Michele Vecchione; Brent M Donnellan; John Tisak
Journal:  Psychometrika       Date:  2013-03-01       Impact factor: 2.500

2.  Double dissociation between the neural correlates of the general and specific factors of the Life Orientation Test-Revised.

Authors:  Guido Alessandri; Vilfredo De Pascalis
Journal:  Cogn Affect Behav Neurosci       Date:  2017-10       Impact factor: 3.282

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.